Rectal bleeding due to leiomyosarcoma

Bilel Jideh; Tao Yang; Ian Turner

doi:10.1016/j.cgh.2016.08.008

Rectal bleeding due to leiomyosarcoma

Bilel Jideh, Tao Yang, Ian Turner

Western Sydney University

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

Leiomyosarcoma (LMS) of the gastrointestinal tract (GIT) are extremely rare mesenchymal tumours which account for 0.12% of colon cancers. The incidence of LMS of the colon is 1:100,000. They are usually aggressive, have a high local recurrence rate, and significant haematogenous spread with the liver being the most affected organ.

Original language	English
Pages (from-to)	e1-e2
Number of pages	2
Journal	Clinical Gastroenterology and Hepatology
Volume	15
Issue number	1
DOIs	https://doi.org/10.1016/j.cgh.2016.08.008
Publication status	Published - 2017

Keywords

abnormalities
cancer
colon (anatomy)
hemorrhage
leiomyosarcoma
rectum

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.cgh.2016.08.008

Cite this

@article{eefb07442a4b46d6b2d7d0f2256f7c59,

title = "Rectal bleeding due to leiomyosarcoma",

abstract = "Leiomyosarcoma (LMS) of the gastrointestinal tract (GIT) are extremely rare mesenchymal tumours which account for 0.12% of colon cancers. The incidence of LMS of the colon is 1:100,000. They are usually aggressive, have a high local recurrence rate, and significant haematogenous spread with the liver being the most affected organ.",

keywords = "abnormalities, cancer, colon (anatomy), hemorrhage, leiomyosarcoma, rectum",

author = "Bilel Jideh and Tao Yang and Ian Turner",

year = "2017",

doi = "10.1016/j.cgh.2016.08.008",

language = "English",

volume = "15",

pages = "e1--e2",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - Rectal bleeding due to leiomyosarcoma

AU - Jideh, Bilel

AU - Yang, Tao

AU - Turner, Ian

PY - 2017

Y1 - 2017

N2 - Leiomyosarcoma (LMS) of the gastrointestinal tract (GIT) are extremely rare mesenchymal tumours which account for 0.12% of colon cancers. The incidence of LMS of the colon is 1:100,000. They are usually aggressive, have a high local recurrence rate, and significant haematogenous spread with the liver being the most affected organ.

AB - Leiomyosarcoma (LMS) of the gastrointestinal tract (GIT) are extremely rare mesenchymal tumours which account for 0.12% of colon cancers. The incidence of LMS of the colon is 1:100,000. They are usually aggressive, have a high local recurrence rate, and significant haematogenous spread with the liver being the most affected organ.

KW - abnormalities

KW - cancer

KW - colon (anatomy)

KW - hemorrhage

KW - leiomyosarcoma

KW - rectum

UR - http://handle.uws.edu.au:8081/1959.7/uws:36658

UR - http://www.cghjournal.org/article/S1542-3565(16)30548-1/abstract?showall=true

U2 - 10.1016/j.cgh.2016.08.008

DO - 10.1016/j.cgh.2016.08.008

M3 - Article

SN - 1542-3565

VL - 15

SP - e1-e2

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

IS - 1

ER -

Rectal bleeding due to leiomyosarcoma

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this